Neurotrophic and neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injury-Reference-Cited by-同舟云学术

Neurotrophic and neuroprotective effects of a monomeric GLP-1/GIP/Gcg receptor triagonist in cellular and rodent models of mild traumatic brain injury

Published:2020-02 Issue: Volume:324 Page:113113
ISSN:0014-4886
Container-title:Experimental Neurology
language:en
Short-container-title:Experimental Neurology

Author:

Li Yazhou,Glotfelty Elliot J.,Namdar Inbar,Tweedie David,Olson Lars,Hoffer Barry J.,DiMarchi Richard D.,Pick Chagi G.,Greig Nigel H.

Publisher

Elsevier BV

Subject

Developmental Neuroscience,Neurology

Reference83 articles.

1. Extensive cytotoxic lesions involving both the rhinal cortices and area TE impair recognition but spare spatial alternation in the rat;Aggleton;Brain Res. Bull.,1997

2. Glucagon protects against impaired NMDA-mediated cerebrovasodilation and cerebral autoregulation during hypotension after brain injury by activating cAMP protein kinase a and inhibiting upregulation of tPA;Armstead;J. Neurotrauma,2011

3. Exenatide once weekly versus placebo in Parkinson’s disease: a randomised, double-blind, placebo-controlled trial;Athauda;Lancet,2017

4. What effects might exenatide have on non-motor symptoms in Parkinson’s disease: a post Hoc analysis;Athauda;J. Park. Dis.,2018

5. Exenatide and the treatment of patients with Parkinson’s disease;Aviles-Olmos;J. Clin. Invest.,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incretin-Based Multi-Agonist Peptides Are Neuroprotective and Anti-Inflammatory in Cellular Models of Neurodegeneration;Biomolecules;2024-07-19

2. Type 2 diabetes mellitus/obesity drugs: A neurodegenerative disorders savior or a bridge too far?;Ageing Research Reviews;2024-07

3. DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson’s disease;GeroScience;2024-04-02

4. Sitagliptin elevates plasma and CSF incretin levels following oral administration to nonhuman primates: relevance for neurodegenerative disorders;GeroScience;2024-03-27

5. Prospects of antidiabetic drugs in the treatment of neurodegenerative disease;Brain‐X;2024-02-29